This study investigates barriers to the utilization of antiretroviral therapy among HIV-positive pregnant women in Birnin Kebbi, North West Nigeria. This study concludes that interventions focusing on community education to reduce stigma, correcting misconceptions about therapy safety, improving healthcare infrastructure, and integrating antiretroviral therapy into antenatal care could substantially increase utilization, reduce transmission, and improve maternal and child health outcomes in Nigeria.

https://pubmed.ncbi.nlm.nih.gov/40574719/

References

  1. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440.

  2. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510.

  3. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2002;(2):CD003510.

Categories

Maternal & Infant Health  Maternal Health  Maternal/Fetal health during pregnancy  HIV/AIDS (Mesh)  

Tags

Reply

Please Sign in (or Register) to view further.